Linking peripheral atherosclerosis to blood–brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment

Ádám Nyúl-Tóth,Roland Patai,Anna Csiszar,Anna Ungvari,Rafal Gulej,Peter Mukli,Andriy Yabluchanskiy,Zoltan Benyo,Peter Sotonyi,Calin I. Prodan,Eric M. Liotta,Peter Toth,Fanny Elahi,Péter Barsi,Pál Maurovich-Horvat,Farzaneh A. Sorond,Stefano Tarantini,Zoltan Ungvari

DOI: https://doi.org/10.1007/s11357-024-01194-0

2024-06-05

GeroScience

Abstract:Aging plays a pivotal role in the pathogenesis of cerebral small vessel disease (CSVD), contributing to the onset and progression of vascular cognitive impairment and dementia (VCID). In older adults, CSVD often leads to significant pathological outcomes, including blood–brain barrier (BBB) disruption, which in turn triggers neuroinflammation and white matter damage. This damage is frequently observed as white matter hyperintensities (WMHs) in neuroimaging studies. There is mounting evidence that older adults with atherosclerotic vascular diseases, such as peripheral artery disease, ischemic heart disease, and carotid artery stenosis, face a heightened risk of developing CSVD and VCID. This review explores the complex relationship between peripheral atherosclerosis, the pathogenesis of CSVD, and BBB disruption. It explores the continuum of vascular aging, emphasizing the shared pathomechanisms that underlie atherosclerosis in large arteries and BBB disruption in the cerebral microcirculation, exacerbating both CSVD and VCID. By reviewing current evidence, this paper discusses the impact of endothelial dysfunction, cellular senescence, inflammation, and oxidative stress on vascular and neurovascular health. This review aims to enhance understanding of these complex interactions and advocate for integrated approaches to manage vascular health, thereby mitigating the risk and progression of CSVD and VCID.

geriatrics & gerontology,gerontology

What problem does this paper attempt to address?

The paper primarily explores the association between peripheral arteriosclerosis and blood-brain barrier disruption, and analyzes how this association serves as a manifestation of cerebral small vessel disease (CSVD), thereby affecting vascular cognitive impairment and dementia (VCID). Specifically, the core content of the paper includes:

1. **Background and Importance**: With aging, cerebral small vessel disease plays a crucial role in the occurrence and development of vascular cognitive impairment and dementia. These diseases often lead to blood-brain barrier disruption, causing neuroinflammation and white matter damage.

2. **Research Focus**: This review discusses the complex relationship between peripheral arteriosclerosis (such as peripheral artery disease, ischemic heart disease, and carotid artery stenosis) and cerebral small vessel disease and its related blood-brain barrier disruption. It particularly focuses on how these diseases interact through common pathological mechanisms and how they exacerbate the development of cerebral small vessel disease and vascular cognitive impairment and dementia.

3. **Key Findings**:
- Elderly patients with peripheral arteriosclerosis diseases have a higher risk of developing cerebral small vessel disease and vascular cognitive impairment and dementia.
- Vascular aging is a comprehensive process that affects not only large vessels but also microvessels, leading to cerebral small vessel disease and blood-brain barrier disruption.
- Risk factors for peripheral arteriosclerosis (such as hypertension, hypercholesterolemia, etc.) also promote blood-brain barrier disruption.

4. **Clinical Significance**: Understanding the link between peripheral arteriosclerosis and intracerebral changes is crucial for developing comprehensive treatment methods, slowing the risk and progression of vascular cognitive impairment and dementia.

5. **Future Directions**: The article also discusses current research findings, potential therapeutic targets, and future research directions, aiming to deepen the understanding of this systemic disease and promote the development of more effective prevention and treatment strategies.